B44.8 Other forms of aspergillosis

Name of the Condition

• Other forms of aspergillosis

Summary

Other forms of aspergillosis represent non-invasive or localized infections caused by Aspergillus species, distinct from invasive pulmonary or allergic manifestations. These conditions typically involve colonization of specific tissues or structures without systemic spread, with clinical presentations varying based on host immunity and site of involvement. The spectrum includes conditions like sinus aspergillosis, cutaneous aspergillosis, or localized extrapulmonary disease.

Causes

The condition is caused by Aspergillus species, ubiquitous environmental molds. Spores are inhaled or introduced through direct contact with mucosal surfaces or skin. In susceptible hosts, the fungus may colonize pre-existing cavities, sinuses, or damaged tissue. Unlike invasive disease, the organism does not invade blood vessels or spread systemically, but it can cause localized inflammation or structural changes in the affected area.

Risk Factors

• Chronic sinus disease or prior sinus surgery.
• Skin trauma or burns, particularly in immunocompromised individuals.
• Structural abnormalities in the sinuses or other anatomical sites.
• Prolonged corticosteroid use or mild immunosuppression.
• Environmental exposure to high Aspergillus spore concentrations.
• Prior lung disease with cavitation or bronchiectasis.

Symptoms

• Sinus pain, nasal congestion, or discharge in sinus involvement.
• Skin lesions, ulcers, or nodules in cutaneous forms.
• Chronic cough or localized respiratory symptoms if affecting airways.
• Low-grade fever or malaise in some cases.
• Hemoptysis (coughing up blood) if involving pulmonary structures.
• Weight loss or fatigue in chronic presentations.

Diagnosis

Diagnosis requires clinical correlation with imaging and microbiological or histopathological confirmation. For sinus disease, CT scans may show opacification or bony erosion. Cutaneous lesions may be biopsied to identify fungal elements. Cultures or PCR testing of affected tissues can confirm Aspergillus presence. Distinguishing from invasive disease is critical, as treatment approaches differ. Imaging and tissue sampling help assess extent of involvement and rule out systemic spread.

Treatment Options

Treatment depends on the site and severity of infection. For localized sinus disease, surgical debridement combined with antifungal therapy (e.g., voriconazole) may be used. Cutaneous lesions often respond to topical or systemic antifungals. Chronic colonization may require long-term suppressive therapy. Immunocompromised patients may need prolonged treatment to prevent progression. Adjunctive measures, such as managing underlying conditions, support recovery.

Prognosis and Follow-Up

Prognosis varies by site and host immunity. Localized, non-invasive forms generally have better outcomes than invasive disease, especially with early intervention. Chronic or recurrent cases may require ongoing monitoring. Follow-up includes clinical assessment, imaging, and repeat cultures to ensure resolution. Immunocompromised patients need close surveillance for recurrence or progression.

Complications

• Chronic sinus obstruction or bony destruction.
• Skin necrosis or secondary bacterial infection.
• Progression to invasive disease in high-risk hosts.
• Respiratory compromise if airways are involved.
• Recurrence if underlying conditions persist.

Lifestyle & Prevention

• Avoid high-spore environments (e.g., construction sites, moldy areas).
• Use protective equipment (masks) in dusty settings.
• Manage chronic sinus or lung conditions to reduce susceptibility.
• Practice good wound care to prevent cutaneous infection.
• Maintain immune health through balanced nutrition and medical care.

When to Seek Professional Help

Seek care if symptoms persist or worsen, especially with fever, worsening pain, or new lesions. Immunocompromised individuals should consult promptly with new respiratory or skin symptoms. Early evaluation is critical to prevent progression to invasive disease.

Tips for Medical Coders

Document the specific site or manifestation (e.g., sinus, cutaneous) to support code assignment. Include details on clinical presentation, imaging findings, and microbiological results when available. Ensure differentiation from invasive or allergic forms to justify the "other" classification. Note any underlying conditions or risk factors that may influence coding specificity.